MONMOUTH JUNCTION, N.J., June 23, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“the Company”), a late clinical-stage biopharmaceutical company working to […]
SOUTH SAN FRANCISCO, Calif., June 23, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc. (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing […]